Clinical Trials Logo

Reaction - Mixed Vaccine clinical trials

View clinical trials related to Reaction - Mixed Vaccine.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03357315 Completed - Metastatic Sarcoma Clinical Trials

Mix Vaccine for Metastatic Sarcoma Patients

Start date: November 30, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is the safety and efficacy of mix vaccine to small metastases of sarcoma.

NCT ID: NCT03357289 Completed - Clinical trials for Reaction - Mixed Vaccine

Mix Vaccine for Metastatic Kidney Cancer

Start date: November 30, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is the safety and efficacy of mix vaccine to small metastases of kidney cancer.

NCT ID: NCT03357276 Completed - Clinical trials for Metastatic Colorectal Cancer

Mix Vaccine for Metastatic Colorectal Cancer

Start date: November 30, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is the safety and efficacy of mix vaccine to small metastases of colorectal cancer.